Constellation joins the mega-round club with $100M raise and plans to pursue cancer studies
After keeping a fairly low profile for the past few years, Constellation Pharmaceuticals is stepping into the spotlight this morning, joining the megaround club in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.